KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Receivables - Other: 2012-2025

Historic Receivables - Other for TherapeuticsMD (TXMD) over the last 5 years, with Sep 2025 value amounting to $3.7 million.

  • TherapeuticsMD's Receivables - Other rose 10.29% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 10.29%. This contributed to the annual value of $3.6 million for FY2024, which is 83.49% down from last year.
  • As of Q3 2025, TherapeuticsMD's Receivables - Other stood at $3.7 million, which was down 2.08% from $3.7 million recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Receivables - Other registered a high of $21.6 million during Q4 2023, and its lowest value of $2.9 million during Q2 2024.
  • For the 3-year period, TherapeuticsMD's Receivables - Other averaged around $5.6 million, with its median value being $3.4 million (2024).
  • In the last 5 years, TherapeuticsMD's Receivables - Other tumbled by 83.49% in 2024 and then climbed by 28.71% in 2025.
  • TherapeuticsMD's Receivables - Other (Quarterly) stood at $21.6 million in 2023, then crashed by 83.49% to $3.6 million in 2024, then increased by 10.29% to $3.7 million in 2025.
  • Its Receivables - Other was $3.7 million in Q3 2025, compared to $3.7 million in Q2 2025 and $3.0 million in Q1 2025.